3 Berkshire Stocks Under $30 and 2 Under $30 Greg Abel May Buy

Photo of Alex Sirois
By Alex Sirois Published

Quick Read

  • Kraft Heinz (KHC) trades at $23.96 with a 6.76% dividend yield and forward P/E near 12, posting four consecutive EPS beats while free cash flow jumped 59%, though organic net sales face 1.5-3.5% headwinds. Sirius XM (SIRI) sits at $27.10 with a 4.04% yield and 11 trailing P/E after locking in an exclusive YouTube audio ad partnership, achieving record-low 1.5% churn and 37% podcast revenue growth. Liberty Latin America (LILA) trades at $7.63 with 13% Q1 operating income growth and plans to distribute $500M in preferred stock. Nu Holdings (NU) posts a 23 trailing P/E with 42% full-year revenue growth to $15.77B and 33% Q4 return on equity after securing conditional U.S. national bank approval. Pfizer (PFE) trades at $25.68 pairing a 6.6% yield with a forward P/E of 9, with non-COVID operations growing 9% operationally.

  • Berkshire Hathaway’s Greg Abel is sitting on record cash reserves and scanning the sub-$30 share-price segment for the brand-heavy, cash-generative franchises Warren Buffett favored during market downturns.

  • It sounds nuts, but SoFi is giving new active invest users up to $1,000 in stock for a limited time, and all it takes is a $50 deposit to get started. See for yourself (Sponsor)
    DISCLOSURE:
    INVESTMENTS ARE NOT FDIC INSURED • ARE NOT BANK GUARANTEED • MAY LOSE VALUE Brokerage and Active investing products offered through SoFi Securities LLC, member FINRA(www.finra.org)/SIPC(www.sipc.org). Advisory services are offered by SoFi Wealth LLC, an SEC-registered investment adviser. Information about SoFi Wealth’s advisory operations, services, and fees is set forth in SoFi Wealth’s current Form ADV Part 2 (Brochure), a copy of which is available upon request and at www.adviserinfo.sec.gov. Probability of Member receiving $1,000 is a probability of 0.026%; If you don’t make a selection in 30 days, you’ll no longer qualify for the promo. Customer must fund their account with a minimum of $50.00 to qualify. Other fees, such as exchange fees, may apply. Please view our fee disclosure to view a full listing of fees. Investing in alternative investments and/or strategies may not be suitable for all investors and involves unique risks, including the risk of loss. An investor should consider their individual circumstances and any investment information, such as a prospectus, prior to investing. Interval Funds are illiquid instruments, the ability to trade on your timeline may be restricted. Brokerage and Active investing products offered through SoFi Securities LLC, Member FINRA(www.finra.org) /SIPC(www.sipc.org). There are limitations with fractional shares to consider before investing. During market hours fractional share orders are transmitted immediately in the order received. There may be system delays from receipt of your order until execution and market conditions may adversely impact execution prices. Outside of market hours orders are received on a not held basis and will be aggregated for each security then executed in the morning trade window of the next business day at market open. Share will be delivered at an average price received for executing the securities through a single batched order. Fractional shares may not be transferred to another firm. Fractional shares will be sold when a transfer or closure request is initiated. Please consider that selling securities is a taxable event. Options involve risks, including substantial risk of loss and the possibility an investor may lose the entire investment Before trading options please review the Characteristics and Risks of Standardized Options  Investing in an Initial Public Offering (IPO) involves substantial risk, including the risk of loss. Further, there are a variety of risk factors to consider when investing in an IPO, including but not limited to, unproven management, significant debt, and lack of operating history. For a comprehensive discussion of these risks please refer to SoFi Securities’ IPO Risk Disclosure Statement This should not be considered a recommendation to participate in IPOs and investors should carefully read the offering prospectus to determine whether an offering is consistent with their investment objectives, risk tolerance, and financial situation. New offerings generally have high demand and there are a limited number of shares available for distribution to participants. Many customers may not be allocated shares and share allocations may be significantly smaller than the shares requested in the customer’s initial offer (Indication of Interest). For more information on the allocation process please visit IPO Allocation.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
3 Berkshire Stocks Under $30 and 2 Under $30 Greg Abel May Buy

© Dimitrios Kambouris / Getty Images Entertainment via Getty Images

Warren Buffett built Berkshire Hathaway by paying reasonable prices for durable cash flows, and three of his current bets still trade below $30 a share. With Greg Abel sitting on a record cash pile, the sub-$30 aisle is where value hunters are scanning for the kind of brand-heavy, cash-generative franchises Omaha tends to favor when sentiment sours.

Here are five stocks under $30 that fit the Buffett template: three Berkshire already owns, plus two Abel could plausibly add to the book.

Kraft Heinz (NASDAQ: KHC)

Kraft Heinz (NASDAQ:KHC | KHC Price Prediction) owns Heinz, Philadelphia, Lunchables, and Primal Kitchen. Shares recently traded at $23.96, paying a 6.76% dividend yield at a forward multiple near 12. Q1 adjusted EPS hit $0.58 against a $0.5027 consensus, the fourth consecutive beat, while free cash flow jumped 58.9% to $766M. CEO Steve Cahillane’s $600M reinvestment plan anchors the turnaround case. The risk: organic net sales are guided down 1.5% to 3.5% on SNAP and private-label pressure. With analyst targets clustered near $23.87, the value here lives in the dividend.

Sirius XM (NASDAQ: SIRI)

Sirius XM (NASDAQ:SIRI) operates satellite radio and Pandora and just locked in an exclusive U.S. audio ad partnership covering YouTube’s roughly 255 million monthly listeners. Shares sit near $27.10, up 37.2% year to date, on a trailing P/E of 11 and forward P/E of 9. The dividend yields 4.04% at $0.27 quarterly. Q1 churn hit a record-low 1.5% and podcast revenue grew 37%, with full-year free cash flow guided to $1.35B. The bear note: self-pay subscribers are still shrinking. Wall Street targets average $28.08, leaving the cash return as the main draw.

Liberty Latin America (NASDAQ: LILA)

Liberty Latin America (NASDAQ:LILA) runs broadband and mobile networks across the Caribbean and Latin America under Flow, Liberty, and Más Móvil. Shares recently sat at $7.63, up 63.38% over the past year. Q1 operating income rose 13%, the company added 50,200 postpaid subscribers, and CEO Balan Nair announced plans to distribute $500M in 9% preferred stock. Berkshire still holds the position. The risk is real: net leverage sits at 4.5x and Hurricane Melissa weighed on Caribbean revenue. Analyst targets at $11.90 imply meaningful upside if recovery holds.

Nu Holdings (NYSE: NU)

Nu Holdings (NYSE:NU), Latin America’s largest digital bank, sits outside Berkshire’s current portfolio yet matches the profitable, scale-driven financial profile Abel has flagged interest in. It’s also formerly a Berkshire Hathaway holding. Shares trade near $13.80 at a trailing P/E of 23. Full-year revenue grew 42.06% to $15.77B, net income climbed 45.61% to $2.87B, and Q4 return on equity hit 33%. Nubank also secured conditional OCC approval for a U.S. national bank. Risks include Brazilian macro exposure and $4.20B in expected credit losses. Consensus target sits at $19.87, well above the current quote.

Pfizer (NYSE: PFE)

Pfizer (NYSE:PFE) is another non-Berkshire name that fits the Buffett-style screen Abel may inherit. Shares recently traded at $25.68, up 21.96% over the past year, pairing a 6.6% yield with a forward P/E of 9. The non-COVID portfolio grew 9% operationally in Q4, with Vyndaqel, Eliquis, and Abrysvo all posting double-digit gains. Q4 adjusted EPS came in at $0.66 versus a $0.57 consensus. Risks include a $1.5B loss-of-exclusivity headwind plus Most-Favored-Nation pricing uncertainty. Consensus target stands at $29.11.

A low share price by itself is never a thesis. Each of these names carries a specific risk that could undo the cheap headline multiple, from food-volume erosion to Brazilian macro to drug-pricing reform. Treat this list as a starting point for your own diligence, not a substitute for it.

Photo of Alex Sirois
About the Author Alex Sirois →

Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.

Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.

At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.

Continue Reading

Top Gaining Stocks

F Vol: 216,261,152
ENPH Vol: 11,512,758
ON Vol: 21,618,191
AKAM Vol: 10,964,520
HPE Vol: 27,523,481

Top Losing Stocks

CTRA Vol: 73,319,495
FDS Vol: 1,153,303
CEG Vol: 6,653,829
J Vol: 2,649,092
PODD Vol: 1,990,609